Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Balsa

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
Reumatologia Clinica|July 29, 2011
[What are patients with early rheumatoid arthritis like in Spain? Description of the PROAR cohort]Virginia Villaverde García, Alejandro Balsa, Loreto Carmona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Human T cells constitutively express IL-15 that promotes ex vivo T cell homeostatic proliferation through autocrine/juxtacrine loopsMaría-Eugenia Miranda-Carús, Marta Benito-Miguel, Miguel A Llamas, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 10, 2019
Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patientsMaría Ángeles González-Fernández, Elena Villamañán, Inmaculada Jiménez-Nácher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexateMaría-Eugenia Miranda-Carús, Alejandro Balsa, Marta Benito-Miguel, et al.
Rheumatology International|April 5, 2018
Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic reviewMaría Martín-López, Loreto Carmona, Alejandro Balsa, et al.
Arthritis and Rheumatism|October 1, 2004
Rheumatoid arthritis synovial fluid fibroblasts express TRAIL-R2 (DR5) that is functionally activeMaría-Eugenia Miranda-Carús, Alejandro Balsa, Marta Benito-Miguel, et al.
Reumatologia Clinica|November 15, 2017
Use of Immunomodulatory Drugs at a Uveitis ClinicClaudia Millán-Longo, Diana Peiteado, Armelle Schlincker, et al.
Journal of Clinical Medicine|April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target StrategyPeter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Clinical Rheumatology|July 24, 2019
Unilateral diffuse alveolar hemorrhage in granulomatosis with polyangiitisJuan Molina Collada, Gema Bonilla, Luis Gómez-Carrera, et al.
Therapeutic Advances in Musculoskeletal Disease|October 24, 2024
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?Peter C Taylor, Eugen Feist, Janet E Pope, et al.
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
Reumatologia Clinica|July 29, 2011
[What are patients with early rheumatoid arthritis like in Spain? Description of the PROAR cohort]Virginia Villaverde García, Alejandro Balsa, Loreto Carmona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Human T cells constitutively express IL-15 that promotes ex vivo T cell homeostatic proliferation through autocrine/juxtacrine loopsMaría-Eugenia Miranda-Carús, Marta Benito-Miguel, Miguel A Llamas, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 10, 2019
Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patientsMaría Ángeles González-Fernández, Elena Villamañán, Inmaculada Jiménez-Nácher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexateMaría-Eugenia Miranda-Carús, Alejandro Balsa, Marta Benito-Miguel, et al.
Rheumatology International|April 5, 2018
Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic reviewMaría Martín-López, Loreto Carmona, Alejandro Balsa, et al.
Arthritis and Rheumatism|October 1, 2004
Rheumatoid arthritis synovial fluid fibroblasts express TRAIL-R2 (DR5) that is functionally activeMaría-Eugenia Miranda-Carús, Alejandro Balsa, Marta Benito-Miguel, et al.
Reumatologia Clinica|November 15, 2017
Use of Immunomodulatory Drugs at a Uveitis ClinicClaudia Millán-Longo, Diana Peiteado, Armelle Schlincker, et al.
Journal of Clinical Medicine|April 18, 2019
How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target StrategyPeter C Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, et al.
Clinical Rheumatology|July 24, 2019
Unilateral diffuse alveolar hemorrhage in granulomatosis with polyangiitisJuan Molina Collada, Gema Bonilla, Luis Gómez-Carrera, et al.
Therapeutic Advances in Musculoskeletal Disease|October 24, 2024
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?Peter C Taylor, Eugen Feist, Janet E Pope, et al.
Pageof 25